Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis

Valentina Maria Sofia, Letizia Da Sacco, Cecilia Surace, Anna Cristina Tomaiuolo, Silvia Genovese, Simona Grotta, Maria Gnazzo, Stefano Petrocchi, Laura Ciocca, Federico Alghisi, Enza Montemitro, Luigi Martemucci, Ausilia Elce, Vincenzina Lucidi, Giuseppe Castaldo, Adriano Angioni

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Genetic features of chronic pancreatitis (CP) have been investigated extensively, mainly by testing genes associated to the trypsinogen activation pathway. However, different molecular pathways involving other genes may be implicated in CP pathogenesis. A total of 80 patients with idiopathic chronic pancreatitis (ICP) were investigated using a Next-Generation Sequencing (NGS) approach with a panel of 70 genes related to six different pancreatic pathways: premature activation of trypsinogen, modifier genes of cystic fibrosis phenotype, pancreatic secretion and ion homeostasis, calcium signaling and zymogen granules (ZG) exocytosis, autophagy and autoimmune pancreatitis-related genes. We detected mutations in 34 out of 70 genes examined; of the 80 patients, 64 (80.0%) were positive for mutations in one or more genes and 16 (20.0%) had no mutations. Mutations in CFTR were detected in 32 of the 80 patients (40.0%) and 22 of them exhibited at least one mutation in genes of other pancreatic pathways. Of the remaining 48 patients, 13/80 (16.3%) had mutations in genes involved in premature activation of trypsinogen and 19/80 (23.8%) had mutations only in genes of the other pathways: 38 (59.3%) of the 64 patients positive for mutations showed variants in two or more genes. Our data, although to be extended with functional analysis of novel mutations, suggest a high rate of genetic heterogeneity in CP and that trans-heterozygosity may predispose to the ICP phenotype.

Original languageEnglish
Pages (from-to)300-309
Number of pages10
JournalMolecular Medicine
Volume22
DOIs
Publication statusPublished - 2016

Fingerprint

Genetic Heterogeneity
Chronic Pancreatitis
Mutation
Genes
Trypsinogen
Modifier Genes
Phenotype
Calcium Signaling
Autophagy
Exocytosis
Secretory Vesicles
Cystic Fibrosis
Pancreatitis
Homeostasis
Ions

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis. / Sofia, Valentina Maria; Da Sacco, Letizia; Surace, Cecilia; Tomaiuolo, Anna Cristina; Genovese, Silvia; Grotta, Simona; Gnazzo, Maria; Petrocchi, Stefano; Ciocca, Laura; Alghisi, Federico; Montemitro, Enza; Martemucci, Luigi; Elce, Ausilia; Lucidi, Vincenzina; Castaldo, Giuseppe; Angioni, Adriano.

In: Molecular Medicine, Vol. 22, 2016, p. 300-309.

Research output: Contribution to journalArticle

Sofia, Valentina Maria ; Da Sacco, Letizia ; Surace, Cecilia ; Tomaiuolo, Anna Cristina ; Genovese, Silvia ; Grotta, Simona ; Gnazzo, Maria ; Petrocchi, Stefano ; Ciocca, Laura ; Alghisi, Federico ; Montemitro, Enza ; Martemucci, Luigi ; Elce, Ausilia ; Lucidi, Vincenzina ; Castaldo, Giuseppe ; Angioni, Adriano. / Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis. In: Molecular Medicine. 2016 ; Vol. 22. pp. 300-309.
@article{88bc61a9afb34162bd9b9e86c2d0e220,
title = "Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis",
abstract = "Genetic features of chronic pancreatitis (CP) have been investigated extensively, mainly by testing genes associated to the trypsinogen activation pathway. However, different molecular pathways involving other genes may be implicated in CP pathogenesis. A total of 80 patients with idiopathic chronic pancreatitis (ICP) were investigated using a Next-Generation Sequencing (NGS) approach with a panel of 70 genes related to six different pancreatic pathways: premature activation of trypsinogen, modifier genes of cystic fibrosis phenotype, pancreatic secretion and ion homeostasis, calcium signaling and zymogen granules (ZG) exocytosis, autophagy and autoimmune pancreatitis-related genes. We detected mutations in 34 out of 70 genes examined; of the 80 patients, 64 (80.0{\%}) were positive for mutations in one or more genes and 16 (20.0{\%}) had no mutations. Mutations in CFTR were detected in 32 of the 80 patients (40.0{\%}) and 22 of them exhibited at least one mutation in genes of other pancreatic pathways. Of the remaining 48 patients, 13/80 (16.3{\%}) had mutations in genes involved in premature activation of trypsinogen and 19/80 (23.8{\%}) had mutations only in genes of the other pathways: 38 (59.3{\%}) of the 64 patients positive for mutations showed variants in two or more genes. Our data, although to be extended with functional analysis of novel mutations, suggest a high rate of genetic heterogeneity in CP and that trans-heterozygosity may predispose to the ICP phenotype.",
author = "Sofia, {Valentina Maria} and {Da Sacco}, Letizia and Cecilia Surace and Tomaiuolo, {Anna Cristina} and Silvia Genovese and Simona Grotta and Maria Gnazzo and Stefano Petrocchi and Laura Ciocca and Federico Alghisi and Enza Montemitro and Luigi Martemucci and Ausilia Elce and Vincenzina Lucidi and Giuseppe Castaldo and Adriano Angioni",
year = "2016",
doi = "10.2119/molmed.2016.00010",
language = "English",
volume = "22",
pages = "300--309",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",

}

TY - JOUR

T1 - Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis

AU - Sofia, Valentina Maria

AU - Da Sacco, Letizia

AU - Surace, Cecilia

AU - Tomaiuolo, Anna Cristina

AU - Genovese, Silvia

AU - Grotta, Simona

AU - Gnazzo, Maria

AU - Petrocchi, Stefano

AU - Ciocca, Laura

AU - Alghisi, Federico

AU - Montemitro, Enza

AU - Martemucci, Luigi

AU - Elce, Ausilia

AU - Lucidi, Vincenzina

AU - Castaldo, Giuseppe

AU - Angioni, Adriano

PY - 2016

Y1 - 2016

N2 - Genetic features of chronic pancreatitis (CP) have been investigated extensively, mainly by testing genes associated to the trypsinogen activation pathway. However, different molecular pathways involving other genes may be implicated in CP pathogenesis. A total of 80 patients with idiopathic chronic pancreatitis (ICP) were investigated using a Next-Generation Sequencing (NGS) approach with a panel of 70 genes related to six different pancreatic pathways: premature activation of trypsinogen, modifier genes of cystic fibrosis phenotype, pancreatic secretion and ion homeostasis, calcium signaling and zymogen granules (ZG) exocytosis, autophagy and autoimmune pancreatitis-related genes. We detected mutations in 34 out of 70 genes examined; of the 80 patients, 64 (80.0%) were positive for mutations in one or more genes and 16 (20.0%) had no mutations. Mutations in CFTR were detected in 32 of the 80 patients (40.0%) and 22 of them exhibited at least one mutation in genes of other pancreatic pathways. Of the remaining 48 patients, 13/80 (16.3%) had mutations in genes involved in premature activation of trypsinogen and 19/80 (23.8%) had mutations only in genes of the other pathways: 38 (59.3%) of the 64 patients positive for mutations showed variants in two or more genes. Our data, although to be extended with functional analysis of novel mutations, suggest a high rate of genetic heterogeneity in CP and that trans-heterozygosity may predispose to the ICP phenotype.

AB - Genetic features of chronic pancreatitis (CP) have been investigated extensively, mainly by testing genes associated to the trypsinogen activation pathway. However, different molecular pathways involving other genes may be implicated in CP pathogenesis. A total of 80 patients with idiopathic chronic pancreatitis (ICP) were investigated using a Next-Generation Sequencing (NGS) approach with a panel of 70 genes related to six different pancreatic pathways: premature activation of trypsinogen, modifier genes of cystic fibrosis phenotype, pancreatic secretion and ion homeostasis, calcium signaling and zymogen granules (ZG) exocytosis, autophagy and autoimmune pancreatitis-related genes. We detected mutations in 34 out of 70 genes examined; of the 80 patients, 64 (80.0%) were positive for mutations in one or more genes and 16 (20.0%) had no mutations. Mutations in CFTR were detected in 32 of the 80 patients (40.0%) and 22 of them exhibited at least one mutation in genes of other pancreatic pathways. Of the remaining 48 patients, 13/80 (16.3%) had mutations in genes involved in premature activation of trypsinogen and 19/80 (23.8%) had mutations only in genes of the other pathways: 38 (59.3%) of the 64 patients positive for mutations showed variants in two or more genes. Our data, although to be extended with functional analysis of novel mutations, suggest a high rate of genetic heterogeneity in CP and that trans-heterozygosity may predispose to the ICP phenotype.

UR - http://www.scopus.com/inward/record.url?scp=84987652783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987652783&partnerID=8YFLogxK

U2 - 10.2119/molmed.2016.00010

DO - 10.2119/molmed.2016.00010

M3 - Article

AN - SCOPUS:84987652783

VL - 22

SP - 300

EP - 309

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

ER -